Bezlotoxumab
Zinplava (bezlotoxumab) is an antibody pharmaceutical. Bezlotoxumab was first approved as Zinplava on 2016-10-21. It is used to treat clostridium infections in the USA. It has been approved in Europe to treat pseudomembranous enterocolitis.
| Trade Name | Zinplava |
|---|---|
| Common Name | Bezlotoxumab |
| Indication | clostridium infections, pseudomembranous enterocolitis |
| Drug Class | Monoclonal antibodies |
